NOVO NORDISK A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 979.8 DKK | -0.07% |
|
-0.10% | +40.52% |
| 02:43pm | Novo Nordisk to present 34 abstracts at ADA | CF |
| 17/06 | Health Care Flat as Traders Wait More Obesity-Drug Updates - Health Care Roundup | DJ |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the Decision to File ...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
Pharmaceuticals
Calendar
07/08/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
980.5
DKK
Average target price
934.3
DKK
Spread / Average Target
-4.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +40.52% | 628B | |
| +52.57% | 797B | |
| -7.00% | 351B | |
| +17.15% | 323B | |
| +10.83% | 300B | |
| +17.11% | 244B | |
| +0.90% | 223B | |
| +5.03% | 163B | |
| -5.54% | 153B | |
| -1.64% | 118B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Transcript : Novo Nordisk A/S - Special Call
